Sarepta Therapeutics, Inc. — Director's Dealing 2015

Mar 4, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2015-02-27

Reporting Person: Wigzell Hans Lennart Rudolf (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-27	Common Stock	A	1000.0	$0.0	Acquired	4666	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-27	Non-Qualified Stock Option (right to buy)	$13.9	A	15000.0	Acquired	2025-02-27	Common Stock (15000)	Direct

Footnotes

F1: This Restricted Stock Award will vest in full on the first anniversary of the Issuer's next annual meeting of stockholders.

F2: This option will vest at a rate of 25% annually over four years to commence on the first anniversary of the Issuer's next annual meeting of stockholders.